Cita APA (7a ed.)

Fresno, C. d., Fresno, C. d., García-Arriaza, J., Martínez-Cano, S., Martínez-Cano, S., Heras-Murillo, I., . . . Sancho, D. (2021). The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Fresno, Carlos del, et al. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Fresno, Carlos del, et al. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A, 2021.